Regen BioPharma Inc (RGBP)

[retiredtech]

Looks like a MERGER instead of a Buyout per PDQ Media Pvt Ltd:
"There have been talks among investors of a potential merger with Precigen Inc (NASDAQ: PGEN). These rumours are supported by the fact that Precigen CEO Helen Sabzevari is on Regen’s Scientific Advisory Board. PGEN also has an extensive clinical trial pipeline in Immunology-oncology that includes the making of mRNA vaccines. Both companies use the exact mRNA vaccine mechanism.
Another indication of a merger or acquisition is the filing of an 8K by the company’s CEO David Koos. The 8K he filed would give Koos exclusive control of voting rights in negotiations for the sale of the company to prevent a hostile takeover. He also filed another 8K to resolve a lawsuit. An unresolved case could complicate an acquisition as few companies want to buy a company with legal problems."